EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterizing Antibodies Targeting Antisense Oligonucleotide Phosphorothioate and 2′- O -Methoxyethyl Modifications for Intracellular Trafficking and Biodistribution Studies

Inês Fial, Seth A Farrier, David P Chimento, Carl A Ascoli iD, Xiao Wan iD, Peter L Oliver iD

Nucleic Acid Therapeutics · 01.08.2025 · 35 (4) · 168-181

DOI: 10.1177/21593337251361396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Therapeutics, online erschienen am 21.07.2025. Verfasst von Inês Fial und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Nucleic Acid Therapy Accelerator, Research Complex at Harwell, Didcot, UK. Hauptthemen laut MEDLINE: Oligonucleotides, Antisense, Phosphorothioate Oligonucleotides, Antibodies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of nucleic acid therapeutics (NATs) such as antisense oligonucleotides (ASOs) and small interfering RNAs relies on multiple stages of extra- and intracellular trafficking. Assessing uptake and efficacy often relies on fluorescent tagging of the NAT for imaging, although the exogenous tag undoubtedly influences the kinetics of intracellular transport and does not represent the compound used clinically. Therefore, better methods to assess the cellular and tissue distribution of NATs are needed. Here, we have validated new panels of antibody reagents that target clinically relevant nucleic acid modifications for visualizing ASOs both in vitro and in vivo . Using the ModDetect™ library of antibodies, we have tested ASOs in vitro for intracellular localization by immunocytochemistry and for biodistribution in mouse tissues by immunohistochemistry. Antibodies specific for the commonly used phosphorothioate (PS) or 2′- O -methoxyethyl (2′-MOE) modifications successfully detected gapmer ASOs, facilitating colocalization studies with endosomal markers in 2D and 3D cell models. In addition, we assessed colocalization of anti-PS signals with fluorescently tagged ASOs. Our data demonstrate the utility of these reagents for the NAT field, where modified nucleic acids can be detected irrespective of the nucleotide sequence, rendering the system amenable for multiple clinical and preclinical workflows and quantitative immunoassays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oligonucleotides, AntisensePhosphorothioate OligonucleotidesAntibodiesAnimalsMiceHumansTissue DistributionRNA, Small InterferingEndosomes

Stichwörter der Autor:innen

antisense oligonucleotideendosomeimmunofluorescenceimmunohistochemistrynucleic acid therapeuticsspheroid

Substanzen

Oligonucleotides, AntisensePhosphorothioate OligonucleotidesRNA, Small InterferingAntibodies

Autor:innen und Institutionen

  • Medical Research Council Nucleic Acid Therapy Accelerator, Research Complex at Harwell, Didcot, UK.
  • Rockland Immunochemicals Inc., Limerick, Pennsylvania, USA.

ORCID-Profile: Carl A Ascoli, Xiao Wan, Peter L Oliver

Förderung

  • Medical Research Council

Zitieren

APA

Fial, I., Farrier, S. A., Chimento, D. P., Ascoli, C. A., Wan, X., & Oliver, P. L. (2025). Characterizing Antibodies Targeting Antisense Oligonucleotide Phosphorothioate and 2′- O -Methoxyethyl Modifications for Intracellular Trafficking and Biodistribution Studies. Nucleic Acid Therapeutics, 35(4), 168-181. https://doi.org/10.1177/21593337251361396

Vancouver

Fial I, Farrier SA, Chimento DP, Ascoli CA, Wan X, Oliver PL. Characterizing Antibodies Targeting Antisense Oligonucleotide Phosphorothioate and 2′- O -Methoxyethyl Modifications for Intracellular Trafficking and Biodistribution Studies. Nucleic Acid Therapeutics. 2025;35(4):168-181. doi:10.1177/21593337251361396

BibTeX
@article{Fial2025,
  author = {Fial, Inês and Farrier, Seth A and Chimento, David P and Ascoli, Carl A and Wan, Xiao and Oliver, Peter L},
  title = {Characterizing Antibodies Targeting Antisense Oligonucleotide Phosphorothioate and 2′- O -Methoxyethyl Modifications for Intracellular Trafficking and Biodistribution Studies},
  journal = {Nucleic Acid Therapeutics},
  year = {2025},
  volume = {35},
  number = {4},
  pages = {168--181},
  doi = {10.1177/21593337251361396}
}
Kostenlos starten →